Roseola cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
{{Roseola}} | {{Roseola}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{DAMI}} | ||
==Overview== | ==Overview== |
Revision as of 17:02, 31 May 2017
Roseola Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Roseola cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Roseola cost-effectiveness of therapy |
Risk calculators and risk factors for Roseola cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]